


PFRMAT FRV1
REMARK ========================================================================
AUTHOR Willie Taylor and Robin Munro,
AUTHOR Division of Mathematical Biology,
AUTHOR National Institute for Medical Research,
AUTHOR The Ridgeway, Mill Hill, London NW7 1AA, U.K.
AUTHOR w_taylor@nimr.mrc.ac.uk
AUTHOR Tel. +44-181-959-3666 (ext.2298), FAX +44-181-913-8545
REMARK ========================================================================
REMARK Threading results for the target T0031, compared against a
REMARK Database containing 319 Structures (extended UCLA benchmark set).
REMARK 
REMARK ========================================================================
REMARK T0031 Exfoliative toxin A  
REMARK T0031 from Staphylococcus aureus, 242a.a.
REMARK T0031 Threading target T0031
SEQRES T0031 EVSAEEIKKHEEKWNKYYGVNAFNLPKELFSKVDEKDRQKYPYNTIGNVF
SEQRES T0031 VKGQTSATGVLIGKNTVLTNRHIAKFANGDPSKVSFRPSINTDDNGNTET
SEQRES T0031 PYGEYEVKEILQEPFGAGVDLALIRLKPDQNGVSLGDKISPAKIGTSNDL
SEQRES T0031 KDGDKLELIGYPFDHKVNQMHRSEIELTTLSRGLRYYGFTVPGNSGSGIF
SEQRES T0031 NSNGELVGIHSSKVSHLDREHQINYGVGIGNYVKRIINEKNE
REMARK ========================================================================
REMARK
REMARK  
REMARK 
REMARK   
REMARK block 0 = 11 seqs
REMARK *USER>>T0031; : Exfoliative toxin A from Staphylococcus aureus, 242a.a.
REMARK *USER>>P1;ETB_STAAU:93 :        EXFOLIATIVE TOXIN B PRECURSOR (EC 3.4.21.-) (EPIDERMOLYTIC TOXIN B). - STAPHYLOCOCCUS AUREUS.
REMARK *USER>>1gctA :  1GCT A  1.60  1-146 (141) -1.0 -1.0 (  1.4 39.7) 1  12.07 =  GAMMA-*CHYMOTRYPSIN *A (E.C.3.4.21.1) ($P*H 7.0) BOVINE (BOS $TAURUS) PANCREAS
REMARK *USER>>2cha :   2CHA    2.00  1-146 (139) 21.6 71.9 (  1.4 39.6) 1   0.00 =  ALPHA CHYMOTRYPSIN A (TOSYLATED) (E.C.3.4.21.1) COW (BOS TAURUS)
REMARK *USER>>1smfE :  1SMF E  2.10  16-245 (223)  9.9  0.0 ( 11.2 34.5) 0   7.44 =  TRYPSIN (E.C.3.4.21.4) COMPLEXED WITH BOWMAN-BIRK INHIBITOR TRYPSIN: BOVINE (BOS TAURUS
REMARK *USER>>1lmwB :  1LMW B  2.50  16-245 (248) 14.5 29.0 ( 10.1 37.1) 0  35.28 =  MOL_ID: 1; MOLECULE: UROKINASE-TYPE PLASMINOGEN ACTIVATOR; CHAIN: A, B, C, D; SYNONYM:
REMARK *USER>>1hf1 :   1HF1   -1.00  1-234 (234) -1.0 -1.0 ( 10.7 34.2) 0   0.00 =  HANNUKA FACTOR (MODEL) HUMAN (HOMO $SAPIENS)
REMARK *USER>>1thsH :  1THS H  2.20  16-247 (252) -1.0 -1.0 ( 12.7 36.5) 1  26.16 =  ALPHA-THROMBIN (E.C.3.4.21.5) COMPLEX WITH MDL-28050 THROMBIN: HUMAN (HOMO SAPIENS) PLA
REMARK *USER>>1ppbB :  1PPB B  1.90  16-247 (259) -1.0 -1.0 ( 11.6 35.5) 0  19.75 =  THROMBIN EC 3.4.21.5 IN COVALENT COMPLEX WITH D-PHEPROARG CHLOROMETHYLHETON (PPACK) OF
REMARK *USER>>1etrH :  1ETR H  2.20  16-247 (259) 14.3 46.3 ( 13.1 37.5) 0  21.96 =  EPSILON-THROMBIN (E.C.3.4.21.5) NON-COVALENT COMPLEX WITH MQPA BOVINE (BOS TAURUS)
REMARK *USER>>1hcgA :  1HCG A  2.20  16-251 (236) 14.4  0.0 ( 14.4 36.0) 1  25.27 =  BLOOD COAGULATION FACTOR XA HUMAN (HOMO SAPIENS)
REMARK 
REMARK EVSAEEIKKHEEKWNKYYGVN
REMARK eysaeeirklkqkfe
REMARK 
REMARK AFNLPKELFSKVDEKDRQKYPYNTIGNVFVK       GQTSATGVLIGKNTVLTNRHIAKFANGD
REMARK vpptdkelythitdnars  pynsvgtvfvk       gstlatgvligkntivTNYHVAREAAKN
REMARK            IVNGEEA VPGSWPWQVSLQ    DKTGFHFCGGSLINENWVVTAAHCG    VT
REMARK            IVNGEEA VPGSWPWQVSLQ    DKTGFHFCGGSLINENWVVTAAHCG    VT
REMARK            IVGGYTC GANTVPYQVSLN      SGYHFCGGSLINSQWVVSAAHCY    KS
REMARK            IIGGEFT TIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFID  YP
REMARK            IIGGNEV TPHSRPYMVLLS   LD  RKTICAGALIAKDWVLTAAHCNLNKRSQ
REMARK            IVEGSDA EIGMSPWQVMLF   RKSPQELLCGASLISDRWVLTAAHCLLYPPWD
REMARK            IVEGSDA EIGMSPWQVMLF   RKSPQELLCGASLISDRWVLTAAHCLLYPPWD
REMARK            IVEGQDA EVGLSPWQVMLF   RKSPQELLCGASLISDRWVLTAAHCLLYPPWD
REMARK            IVGGQEC KDGECPWQALLI   NEE NEGFCGGTILSEFYILTAAHCLYQAKRF
REMARK 
REMARK       PSKVSFRPSINTD DNGNT ETPYGEYEVKEILQEPFGAGVDLALIRLKPD     QNGVSLGDKISP
REMARK       PSNIIFTPAQNRD AEKNEFPTPYGKFEAEEIKESPYGQGLDLAIIKLKpn     ekgesagdliqp
REMARK T     SDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTI  NNDITLLKLSTA    ASFSQTVSAVCLP   SAS
REMARK T     SDVVVAGEFDQGSSSEKIQKLKIAKVFKNSKYNSLTI  NNDITLLKLSTA    ASFSQTVSAVCLP   SAS
REMARK       GIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTL  NNDIMLIKLKSA    ASLNSRVASISLP   TSC
REMARK E     DYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLP   SMY
REMARK        KKVILGAHSITREEPT  KQIMLVKKEFPYPCYDPATREGDLKLLQLTEK    AKINKYVTILHLPKKGDDV
REMARK KNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKP    VAFSDYIHPVCLPDRETAA
REMARK KNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKP    VAFSDYIHPVCLPDRETAA
REMARK KNFTVDDLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRP    IELSDYIHPVCLPDKQTAA
REMARK         KVRVGDRN TEQEEGGEAVHEVEVVIKHNRFT KETYDFDIAVLRLKTP    ITFRMNVAPACLPERDWAE
REMARK 
REMARK    AKIGTSNDLKDGDK               LELIGYPFDHKVNQMH  RSE    IELTTLSRGL    RYYGFTVPG
REMARK    anipdhidiqkgdk               ysllgypynysaysly  qsq    iemfndsq       yfgytevg
REMARK DDFAAGTTCVTTGWGLTRYT         PDRLQQASLPLLSNTNCKK  YWGTK  IKDAMICAG  ASGV   SSCMG
REMARK DDFAAGTTCVTTGWGLTRYANT       PDRLQQASLPLLSNTNCKK  YWGTK  IKDAMICAG  ASGV   SSCMG
REMARK AS  AGTQCLISGWGNTKSSGTSY     PDVLKCLKAPILSDSSCKS  AYPGQ  ITSNMFCAGYLEGGK   DSCQG
REMARK NDPQFGTSCEITGFGKENSTDYLY     PEQLKMTVVKLISHRECQQPHYYGSE  VTTKMLCAADPQWKT   DSCQG
REMARK K   PGTMCQVAGWGRTHNSASWS      DTLREVNITIIDRKVCNDRNHYNFNPVIGMNMVCAGSLRGGR   DSCNG
REMARK SLLQAGYKGRVTGWGNLKET       GQPSVLQVVNLPIVERPVCKDSTRIR    ITDNMFCAGYKPDEGKRGDACEG
REMARK SLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIR    ITDNMFCAGYKPDEGKRGDACEG
REMARK KLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIR    ITDNMFCAGYKPGEGKRGDACEG
REMARK STLMTQKTGIVSGFGRTHSTR           LKMLEVPYVDRNSCKLSSSFI    ITQNMFCAGY   DTKQEDACQG
REMARK 
REMARK NSGSGIFNSNG     ELVGIHSSK VSH LDREHQINYGVGIGN   YVKRIINEKNE          
REMARK nsgsgifnlkg     eligihsgkggqhnlpigvffnrkisslysvdntfgdtlgndlkkrakldk            
REMARK DSGGPLVCKK  NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVN   WVQQTLAAN      
REMARK DSGGPLVCKK  NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVN   WVQQTLAAN      
REMARK DSGGPVVCSG      KLQGIVSWGSGCAQKNKPGVYTKVCNYVS   WIKQTIASN      
REMARK DSGGPLVCSL  QGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLP   WIRSHTKEE      
REMARK DSGSPLLCEGV      FRGVTSFGLENKCGDPRGPGVYILLSKKHLNWIIMTIKGAV     
REMARK DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKK   WIQKVIDQFGE    
REMARK DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKK   WIQKVIDQFGE    
REMARK DSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKK   WIQKVIDRLGS    
REMARK DSGGPHVTR  FKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLK   WIDRSMKTRGLPKAK
REMARK 
REMARK 
REMARK  Above is presented an alignment of the target with several
REMARK  structures.  A threading output format (TALIGN) has been included
REMARK  for the first structure in the alignment (1GCT, A chain), but
REMARK  not for any of the others.  They would be fairly similar, as can be seen
REMARK  from the alignment.
REMARK 
REMARK 
REMARK 
REMARK          5        10        15        20        25        30        35        40
REMARK  E V S A E E I K K H E E K W N K Y Y G V N A F N L P K E L F S K V D E K D R Q K 
REMARK                                                                 16----------22
REMARK
REMARK         45        50        55        60        65        70        75        80
REMARK  Y P Y N T I G N V F V K G Q T S A T G V L I G K N T V L T N R H I A K F A N G D 
REMARK 23--------------------3438----------------------------------------59        6061
REMARK
REMARK         85        90        95       100       105       110       115       120
REMARK  P S K V S F R P S I N T D D N G N T E T P Y G E Y E V K E I L Q E P F G A G V D 
REMARK 63----------------------7577------8183------------------------------99    00----
REMARK
REMARK        125       130       135       140       145       150       155       160
REMARK  L A L I R L K P D Q N G V S L G D K I S P A K I G T S N D L K D G D K L E L I G 
REMARK  ---------------1113--------------------2431------------------------4455--------
REMARK
REMARK        165       170       175       180       185       190       195       200
REMARK  Y P F D H K V N Q M H R S E I E L T T L S R G L R Y Y G F T V P G N S G S G I F 
REMARK  -------------------------7376--------------84  88      89----------------------
REMARK
REMARK        205       210       215       220       225       230       235       240
REMARK  N S N G E L V G I H S S K V S H L D R E H Q I N Y G V G I G N Y V K R I I N E K 
REMARK  ---03  08--------------1618--2022--------------------------------------------45
REMARK
REMARK  242
REMARK  N E
REMARK
REMARK
REMARK
REMARK ========================================================================
TSCORE T0031 0  1.0     1GCT A 0
REMARK ========================================================================
TALIGN T0031 0   33   39        1GCT A 0         16   22        1.0     1
TALIGN T0031 0   41   52        1GCT A 0         23   34        1.0     1
TALIGN T0031 0   53   74        1GCT A 0         38   59        1.0     1
TALIGN T0031 0   79   80        1GCT A 0         60   61        1.0     1
TALIGN T0031 0   81   93        1GCT A 0         63   75        1.0     1
TALIGN T0031 0   94   98        1GCT A 0         77   81        1.0     1
TALIGN T0031 0   99  115        1GCT A 0         83   99        1.0     1
TALIGN T0031 0  118  129        1GCT A 0        100  111        1.0     1
TALIGN T0031 0  130  141        1GCT A 0        113  124        1.0     1
TALIGN T0031 0  142  155        1GCT A 0        131  144        1.0     1
TALIGN T0031 0  156  174        1GCT A 0        155  173        1.0     1
TALIGN T0031 0  175  183        1GCT A 0        176  184        1.0     1
TALIGN T0031 0  185  185        1GCT A 0        188  188        1.0     1
TALIGN T0031 0  189  203        1GCT A 0        189  203        1.0     1
TALIGN T0031 0  205  213        1GCT A 0        208  216        1.0     1
TALIGN T0031 0  214  216        1GCT A 0        218  220        1.0     1
TALIGN T0031 0  217  240        1GCT A 0        222  245        1.0     1
REMARK ========================================================================


